P01 NS023349/NS/NINDS NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1990	1
1998	2
1999	1
2000	2
2001	2
2002	4
2003	3
2004	1
2005	1
2006	3
2007	7
2008	6
2009	6
2010	2
2011	2
2017	2
2024	0

1

The role of infections in autoimmune disease.

Ercolini AM, Miller SD. Ercolini AM, et al. Clin Exp Immunol. 2009 Jan;155(1):1-15. doi: 10.1111/j.1365-2249.2008.03834.x. Clin Exp Immunol. 2009. PMID: 19076824 Free PMC article. Review.

2

Glial toll-like receptor signaling in central nervous system infection and autoimmunity.

Carpentier PA, Duncan DS, Miller SD. Carpentier PA, et al. Brain Behav Immun. 2008 Feb;22(2):140-7. doi: 10.1016/j.bbi.2007.08.011. Epub 2007 Oct 24. Brain Behav Immun. 2008. PMID: 17920811 Free PMC article. Review.

3

Antiviral immune responses: triggers of or triggered by autoimmunity?

Münz C, Lünemann JD, Getts MT, Miller SD. Münz C, et al. Nat Rev Immunol. 2009 Apr;9(4):246-58. doi: 10.1038/nri2527. Nat Rev Immunol. 2009. PMID: 19319143 Free PMC article. Review.

4

Targeting the GM-CSF receptor for the treatment of CNS autoimmunity.

Ifergan I, Davidson TS, Kebir H, Xu D, Palacios-Macapagal D, Cann J, Rodgers JM, Hunter ZN, Pittet CL, Beddow S, Jones CA, Prat A, Sleeman MA, Miller SD. Ifergan I, et al. J Autoimmun. 2017 Nov;84:1-11. doi: 10.1016/j.jaut.2017.06.005. Epub 2017 Jun 20. J Autoimmun. 2017. PMID: 28641926 Free PMC article.

5

Apoptotic cells, including macrophages, are prominent in Theiler's virus-induced inflammatory, demyelinating lesions.

Schlitt BP, Felrice M, Jelachich ML, Lipton HL. Schlitt BP, et al. J Virol. 2003 Apr;77(7):4383-8. doi: 10.1128/jvi.77.7.4383-4388.2003. J Virol. 2003. PMID: 12634394 Free PMC article.

6

Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice.

Jeong SJ, Cooper JG, Ifergan I, McGuire TL, Xu D, Hunter Z, Sharma S, McCarthy D, Miller SD, Kessler JA. Jeong SJ, et al. Neurobiol Dis. 2017 Dec;108:73-82. doi: 10.1016/j.nbd.2017.08.006. Epub 2017 Aug 18. Neurobiol Dis. 2017. PMID: 28823935 Free PMC article.

7

CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease.

Neville KL, Dal Canto MC, Bluestone JA, Miller SD. Neville KL, et al. J Virol. 2000 Sep;74(18):8349-57. doi: 10.1128/jvi.74.18.8349-8357.2000. J Virol. 2000. PMID: 10954534 Free PMC article.

8

Hematopoietic cell activation in the subventricular zone after Theiler's virus infection.

Goings GE, Greisman A, James RE, Abram LK, Begolka WS, Miller SD, Szele FG. Goings GE, et al. J Neuroinflammation. 2008 Oct 15;5:44. doi: 10.1186/1742-2094-5-44. J Neuroinflammation. 2008. PMID: 18922161 Free PMC article.

9

Activation of tumor suppressor protein p53 is required for Theiler's murine encephalomyelitis virus-induced apoptosis in M1-D macrophages.

Son KN, Pugazhenthi S, Lipton HL. Son KN, et al. J Virol. 2009 Oct;83(20):10770-7. doi: 10.1128/JVI.01030-09. Epub 2009 Aug 5. J Virol. 2009. PMID: 19656889 Free PMC article.

10

Differential outcome of tolerance induction in naive versus activated Theiler's virus epitope-specific CD8+ cytotoxic T cells.

Getts MT, Kim BS, Miller SD. Getts MT, et al. J Virol. 2007 Jun;81(12):6584-93. doi: 10.1128/JVI.00008-07. Epub 2007 Apr 11. J Virol. 2007. PMID: 17428853 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

42 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year